LogicMark (LGMK) Competitors $0.0033 +0.00 (+6.45%) As of 10/10/2025 03:57 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock LGMK vs. AMIX, LUCY, GCTK, PTHL, NAOV, BBLG, WOK, QNRX, NDRA, and IVFShould you be buying LogicMark stock or one of its competitors? The main competitors of LogicMark include Autonomix Medical (AMIX), Innovative Eyewear (LUCY), GlucoTrack (GCTK), Pheton (PTHL), Nanovibronix (NAOV), Bone Biologics (BBLG), WORK Medical Technology Group (WOK), Quoin Pharmaceuticals (QNRX), ENDRA Life Sciences (NDRA), and INVO Fertility (IVF). These companies are all part of the "medical equipment" industry. LogicMark vs. Its Competitors Autonomix Medical Innovative Eyewear GlucoTrack Pheton Nanovibronix Bone Biologics WORK Medical Technology Group Quoin Pharmaceuticals ENDRA Life Sciences INVO Fertility Autonomix Medical (NASDAQ:AMIX) and LogicMark (NASDAQ:LGMK) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, valuation, earnings, analyst recommendations, profitability, risk and dividends. Which has more risk & volatility, AMIX or LGMK? Autonomix Medical has a beta of -2.8, meaning that its stock price is 380% less volatile than the S&P 500. Comparatively, LogicMark has a beta of 1.6, meaning that its stock price is 60% more volatile than the S&P 500. Does the media favor AMIX or LGMK? In the previous week, Autonomix Medical had 6 more articles in the media than LogicMark. MarketBeat recorded 6 mentions for Autonomix Medical and 0 mentions for LogicMark. Autonomix Medical's average media sentiment score of 0.84 beat LogicMark's score of 0.00 indicating that Autonomix Medical is being referred to more favorably in the media. Company Overall Sentiment Autonomix Medical Positive LogicMark Neutral Do analysts prefer AMIX or LGMK? Autonomix Medical presently has a consensus price target of $5.00, suggesting a potential upside of 350.45%. Given Autonomix Medical's stronger consensus rating and higher possible upside, research analysts clearly believe Autonomix Medical is more favorable than LogicMark.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Autonomix Medical 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00LogicMark 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders and institutionals have more ownership in AMIX or LGMK? 10.8% of Autonomix Medical shares are held by institutional investors. Comparatively, 7.9% of LogicMark shares are held by institutional investors. 6.2% of Autonomix Medical shares are held by insiders. Comparatively, 2.2% of LogicMark shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Is AMIX or LGMK more profitable? Autonomix Medical has a net margin of 0.00% compared to LogicMark's net margin of -141.96%. LogicMark's return on equity of -124.91% beat Autonomix Medical's return on equity.Company Net Margins Return on Equity Return on Assets Autonomix MedicalN/A -172.93% -133.39% LogicMark -141.96%-124.91%-92.05% Which has better earnings and valuation, AMIX or LGMK? Autonomix Medical has higher earnings, but lower revenue than LogicMark. Autonomix Medical is trading at a lower price-to-earnings ratio than LogicMark, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAutonomix MedicalN/AN/A-$11.41M-$5.74-0.19LogicMark$9.88M0.19-$14.55M-$223.500.00 SummaryAutonomix Medical beats LogicMark on 10 of the 15 factors compared between the two stocks. Get LogicMark News Delivered to You Automatically Sign up to receive the latest news and ratings for LGMK and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LGMK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LGMK vs. The Competition Export to ExcelMetricLogicMarkSurgical appliances & supplies IndustryIndustrials SectorNASDAQ ExchangeMarket Cap$1.90M$24.68M$7.87B$10.63BDividend YieldN/AN/A4.58%4.71%P/E Ratio0.0012.70299.9026.57Price / Sales0.191.841,343.42132.63Price / CashN/A12.8028.3162.09Price / Book0.001.874.856.53Net Income-$14.55M-$5.31M$791.48M$275.96M7 Day PerformanceN/A5.46%-1.02%-0.74%1 Month PerformanceN/A-5.32%2.99%3.71%1 Year PerformanceN/A-19.55%26.09%37.30% LogicMark Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LGMKLogicMark0.159 of 5 stars$0.00+6.5%N/A-99.8%$1.90M$9.88M0.0020AMIXAutonomix Medical2.7244 of 5 stars$1.07+0.5%$5.00+369.5%-90.5%$6.59MN/A-0.191News CoveragePositive NewsAnalyst ForecastLUCYInnovative Eyewear1.004 of 5 stars$1.94-1.3%N/A-76.1%$6.38M$1.98M-0.709Analyst ForecastGCTKGlucoTrack0.331 of 5 stars$6.13-4.1%N/A-99.7%$5.51MN/A-0.115Analyst ForecastPTHLPhetonN/A$0.81-1.7%N/A-86.3%$5.30M$450K0.0011Positive NewsAnalyst ForecastGap DownNAOVNanovibronix0.4165 of 5 stars$5.68-3.2%N/A-90.1%$4.54M$2.56M-0.4220Positive NewsAnalyst ForecastGap DownBBLGBone Biologics0.8165 of 5 stars$2.51+3.7%N/A-75.9%$4.52MN/A0.002WOKWORK Medical Technology GroupN/A$0.08+5.8%N/A-98.5%$4.37M$10.74M0.00226News CoverageAnalyst ForecastQNRXQuoin Pharmaceuticals1.0383 of 5 stars$7.16+1.6%N/A+11.4%$4.22MN/A-0.174Trending NewsGap UpNDRAENDRA Life Sciences1.6861 of 5 stars$5.49-0.1%$50.00+810.1%-15.8%$4.14MN/A-0.1620Positive NewsAnalyst ForecastIVFINVO Fertility0.5521 of 5 stars$0.81-1.6%N/A-97.0%$3.51M$6.53M-0.0110News CoveragePositive NewsAnalyst Forecast Related Companies and Tools Related Companies AMIX Competitors LUCY Competitors GCTK Competitors PTHL Competitors NAOV Competitors BBLG Competitors WOK Competitors QNRX Competitors NDRA Competitors IVF Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LGMK) was last updated on 10/11/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LogicMark, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LogicMark With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
